Stock Analysis on Net

Allergan Inc. (NYSE:AGN.)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 19, 2015.

Common-Size Balance Sheet: Assets

Paying users area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Allergan Inc., common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Cash and equivalents
Short-term investments
Trade receivables, net
Inventories
Prepaid expenses
Deferred taxes
Foreign currency derivative assets
Other
Other current assets
Assets of discontinued operations
Current assets
Deferred executive compensation investments
Capitalized software
Prepaid pensions
Prepaid royalties
Interest rate swap fair value
Debt issuance costs
Equity investments
Other
Investments and other assets
Deferred tax assets
Property, plant and equipment, net
Goodwill
Intangibles, net
Non-current assets
Total assets

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Allergan Inc. current assets as a percentage of total assets increased from 2012 to 2013 and from 2013 to 2014.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Allergan Inc. property, plant and equipment, net as a percentage of total assets decreased from 2012 to 2013 and from 2013 to 2014.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Allergan Inc. non-current assets as a percentage of total assets decreased from 2012 to 2013 and from 2013 to 2014.